206 related articles for article (PubMed ID: 29615487)
1. Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
Smith T; Muller DC; Moons KGM; Cross AJ; Johansson M; Ferrari P; Fagherazzi G; Peeters PHM; Severi G; Hüsing A; Kaaks R; Tjonneland A; Olsen A; Overvad K; Bonet C; Rodriguez-Barranco M; Huerta JM; Barricarte Gurrea A; Bradbury KE; Trichopoulou A; Bamia C; Orfanos P; Palli D; Pala V; Vineis P; Bueno-de-Mesquita B; Ohlsson B; Harlid S; Van Guelpen B; Skeie G; Weiderpass E; Jenab M; Murphy N; Riboli E; Gunter MJ; Aleksandrova KJ; Tzoulaki I
Gut; 2019 Apr; 68(4):672-683. PubMed ID: 29615487
[TBL] [Abstract][Full Text] [Related]
2. External validation of risk prediction models for incident colorectal cancer using UK Biobank.
Usher-Smith JA; Harshfield A; Saunders CL; Sharp SJ; Emery J; Walter FM; Muir K; Griffin SJ
Br J Cancer; 2018 Mar; 118(5):750-759. PubMed ID: 29381683
[TBL] [Abstract][Full Text] [Related]
3. Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts.
Rothwell JA; Bešević J; Dimou N; Breeur M; Murphy N; Jenab M; Wedekind R; Viallon V; Ferrari P; Achaintre D; Gicquiau A; Rinaldi S; Scalbert A; Huybrechts I; Prehn C; Adamski J; Cross AJ; Keun H; Chadeau-Hyam M; Boutron-Ruault MC; Overvad K; Dahm CC; Nøst TH; Sandanger TM; Skeie G; Zamora-Ros R; Tsilidis KK; Eichelmann F; Schulze MB; van Guelpen B; Vidman L; Sánchez MJ; Amiano P; Ardanaz E; Smith-Byrne K; Travis R; Katzke V; Kaaks R; Derksen JWG; Colorado-Yohar S; Tumino R; Bueno-de-Mesquita B; Vineis P; Palli D; Pasanisi F; Eriksen AK; Tjønneland A; Severi G; Gunter MJ
BMC Med; 2023 Feb; 21(1):80. PubMed ID: 36855092
[TBL] [Abstract][Full Text] [Related]
4. External Validation of Risk Prediction Models Incorporating Common Genetic Variants for Incident Colorectal Cancer Using UK Biobank.
Saunders CL; Kilian B; Thompson DJ; McGeoch LJ; Griffin SJ; Antoniou AC; Emery JD; Walter FM; Dennis J; Yang X; Usher-Smith JA
Cancer Prev Res (Phila); 2020 Jun; 13(6):509-520. PubMed ID: 32071122
[TBL] [Abstract][Full Text] [Related]
5. Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.
Briggs SEW; Law P; East JE; Wordsworth S; Dunlop M; Houlston R; Hippisley-Cox J; Tomlinson I
BMJ; 2022 Nov; 379():e071707. PubMed ID: 36351667
[TBL] [Abstract][Full Text] [Related]
6. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
[TBL] [Abstract][Full Text] [Related]
7. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
8. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
9. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study.
Jung AW; Holm PC; Gaurav K; Hjaltelin JX; Placido D; Mortensen LH; Birney E; Brunak SR; Gerstung M
Lancet Digit Health; 2024 Jun; 6(6):e396-e406. PubMed ID: 38789140
[TBL] [Abstract][Full Text] [Related]
10. External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank.
Abhari RE; Thomson B; Yang L; Millwood I; Guo Y; Yang X; Lv J; Avery D; Pei P; Wen P; Yu C; Chen Y; Chen J; Li L; Chen Z; Kartsonaki C
BMC Med; 2022 Sep; 20(1):302. PubMed ID: 36071519
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts.
Karavasiloglou N; Hughes DJ; Murphy N; Schomburg L; Sun Q; Seher V; Rohrmann S; Weiderpass E; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Kaaks R; Kuhn T; Schulze MB; Tumino R; Panico S; Masala G; Pala V; Sacerdote C; Derksen JWG; Skeie G; Hjartåker A; Lasheras C; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Amiano P; Van Guelpen B; Gylling B; Bradbury KE; Papier K; Freisling H; Aglago EK; Cross AJ; Riboli E; Aune D; Gunter MJ; Jenab M
Am J Clin Nutr; 2023 Jan; 117(1):33-45. PubMed ID: 36789942
[TBL] [Abstract][Full Text] [Related]
12. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
13. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
[TBL] [Abstract][Full Text] [Related]
14. The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study.
Smith T; Gunter MJ; Tzoulaki I; Muller DC
Br J Cancer; 2018 Oct; 119(8):1036-1039. PubMed ID: 30323197
[TBL] [Abstract][Full Text] [Related]
15. Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.
Li M; Lin Y; Zhong X; Huang R; Zhang S; Liu M; Liu S; Ye X; Xu X; Huang Y; Xiong Z; Guo Y; Liao X; Zhuang X
Eur J Prev Cardiol; 2023 Oct; 30(14):1427-1438. PubMed ID: 37036042
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score.
Aleksandrova K; Reichmann R; Kaaks R; Jenab M; Bueno-de-Mesquita HB; Dahm CC; Eriksen AK; Tjønneland A; Artaud F; Boutron-Ruault MC; Severi G; Hüsing A; Trichopoulou A; Karakatsani A; Peppa E; Panico S; Masala G; Grioni S; Sacerdote C; Tumino R; Elias SG; May AM; Borch KB; Sandanger TM; Skeie G; Sánchez MJ; Huerta JM; Sala N; Gurrea AB; Quirós JR; Amiano P; Berntsson J; Drake I; van Guelpen B; Harlid S; Key T; Weiderpass E; Aglago EK; Cross AJ; Tsilidis KK; Riboli E; Gunter MJ
BMC Med; 2021 Jan; 19(1):1. PubMed ID: 33390155
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation study.
Keene DJ; Schlüssel MM; Thompson J; Hagan DA; Williams MA; Byrne C; Goodacre S; Cooke M; Gwilym S; Hormbrey P; Bostock J; Haywood K; Wilson D; Collins GS; Lamb SE
Health Technol Assess; 2018 Nov; 22(64):1-112. PubMed ID: 30474592
[TBL] [Abstract][Full Text] [Related]
18. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Risk Scores for All-Cause Mortality for a Smartphone-Based "General Health Score" App: Prospective Cohort Study Using the UK Biobank.
Clift AK; Le Lannou E; Tighe CP; Shah SS; Beatty M; Hyvärinen A; Lane SJ; Strauss T; Dunn DD; Lu J; Aral M; Vahdat D; Ponzo S; Plans D
JMIR Mhealth Uhealth; 2021 Feb; 9(2):e25655. PubMed ID: 33591285
[TBL] [Abstract][Full Text] [Related]
20. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
Parsons RE; Liu X; Collister JA; Clifton DA; Cairns BJ; Clifton L
Heart; 2023 Oct; 109(22):1690-1697. PubMed ID: 37423742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
